tiprankstipranks
Trending News
More News >
Church & Dwight Company (CHD)
NYSE:CHD
Advertisement

Church & Dwight (CHD) AI Stock Analysis

Compare
942 Followers

Top Page

CHD

Church & Dwight

(NYSE:CHD)

Select Model
Select Model
Select Model
Neutral 67 (OpenAI - 4o)
Rating:67Neutral
Price Target:
$96.00
▲(9.48% Upside)
Church & Dwight's overall stock score reflects a strong financial performance and positive earnings call highlights, such as the Touchland acquisition and international growth. However, technical analysis indicates bearish trends, and valuation metrics suggest the stock may be overvalued. Challenges in certain business segments and margin pressures also weigh on the score.
Positive Factors
Cash Flow Management
Strong cash flow growth indicates efficient operations and provides the company with the flexibility to invest in growth opportunities and return value to shareholders.
International Market Growth
The growth in international markets suggests successful expansion strategies and diversification of revenue streams, enhancing long-term stability and growth potential.
Acquisition Success
Successful acquisitions like Touchland strengthen the product portfolio and market position, driving future growth and competitive advantage.
Negative Factors
Gross Margin Pressure
Declining gross margins due to inflation and tariffs can impact profitability and require strategic cost management to maintain financial health.
Vitamin Business Challenges
Struggles in the vitamin segment highlight challenges in product revitalization and market competitiveness, potentially affecting overall growth.
U.S. Consumer Business Decline
Declining sales in the key U.S. market indicate potential issues with consumer demand or pricing strategies, which could impact future revenue.

Church & Dwight (CHD) vs. SPDR S&P 500 ETF (SPY)

Church & Dwight Business Overview & Revenue Model

Company DescriptionChurch & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates through three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; battery-operated and manual toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and replacement showerheads under the WATERPIK brand; FLAWLESS products; cold shortening and relief products under the ZICAM brand; and oral care products under the THERABREATH brand. Its specialty products include animal productivity products, such as MEGALAC rumen bypass fat, a supplement that enables cows to maintain energy levels during the period of high milk production; BIO-CHLOR and FERMENTEN, which are used to reduce health issues associated with calving, as well as provides needed protein; and CELMANAX refined functional carbohydrate, a yeast-based prebiotic. The company offers sodium bicarbonate; and cleaning and deodorizing products. It sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, and websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. The company was founded in 1846 and is headquartered in Ewing, New Jersey.
How the Company Makes MoneyChurch & Dwight generates revenue through the sale of consumer products across several key categories, including laundry and cleaning products, personal care items, and health care products. The company employs a multi-channel distribution strategy that includes retail, e-commerce, and direct-to-consumer sales. Key revenue streams come from established brands like Arm & Hammer and Trojan, which are leaders in their respective markets. Additionally, Church & Dwight invests in marketing and product innovation to drive sales growth. Strategic partnerships with retailers and distributors also enhance their market presence and accessibility, contributing significantly to revenue. Seasonal promotions, product launches, and expanding international markets further bolster the company's financial performance.

Church & Dwight Key Performance Indicators (KPIs)

Any
Any
Consumer Domestic Revenue
Consumer Domestic Revenue
Focuses on revenue generated from domestic consumer sales, providing insight into the company's performance in its home market and its ability to capture and retain local market share.
Chart InsightsChurch & Dwight's Consumer Domestic Revenue shows steady growth in Household Products, but Personal Care Products are facing challenges. Despite recent declines, the earnings call highlighted strategic moves like the acquisition of Touchland and strong brand performances, such as ARM & HAMMER and THERABREATH, which could bolster future growth. However, pressures from tariffs, inflation, and product recalls are impacting margins. The company is focusing on innovation and strategic brand management to navigate these challenges, aiming for modest organic sales growth of 0% to 2% for the year.
Data provided by:Main Street Data

Church & Dwight Earnings Call Summary

Earnings Call Date:Oct 31, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Jan 30, 2026
Earnings Call Sentiment Neutral
Church & Dwight's earnings call presented a mixed picture. The acquisition of Touchland and growth in international markets and online sales were significant positives. However, challenges in the vitamin business, gross margin declines, and issues in the U.S. consumer business and BATISTE brand consumption created areas of concern.
Q2-2025 Updates
Positive Updates
Touchland Acquisition Success
Church & Dwight closed the acquisition of Touchland, which is the fastest-growing brand in the hand sanitizer category in the U.S., and is the #2 hand sanitizer in the category. Touchland experienced strong growth in Q2, outpacing the category and gaining share.
International Segment Growth
International sales grew 5.3% in the quarter, with organic sales increasing by 4.8% due to a combination of higher volume, price, and mix. Growth was led by HERO, THERABREATH, and FEMFRESH.
Online Sales Expansion
Online sales as a percentage of global sales reached 23%, reflecting a continuing trend towards e-commerce.
THERABREATH and HERO Brand Performance
THERABREATH consumption grew 22.5%, maintaining its position as the #2 mouthwash with a 21% share. HERO outpaced the acne category with consumption growth of 11.4%, remaining the #1 brand in acne care with a 22% share.
Negative Updates
Gross Margin Decline
Adjusted gross margin decreased by 40 basis points from a year ago, affected by inflation, tariffs, and a product recall.
Vitamin Business Challenges
The gummy vitamin business was a drag on organic growth, with consumption down around 25% due to TDP declines, despite the category growing almost 4%.
U.S. Consumer Business Sales Decline
Organic sales for the U.S. consumer business declined 1%, with volume growth offset by negative price mix.
BATISTE Consumption Decline
BATISTE experienced a nearly 7% decline in consumption due to competitive price increases, economic pressure driving trade down, and supply issues.
Company Guidance
During the Church & Dwight Second Quarter 2025 Earnings Conference Call, the company provided guidance and insights into its financial performance and strategic initiatives. Organic sales grew by 0.1%, surpassing the initial outlook of minus 2% to flat. The adjusted gross margin decreased by 40 basis points, which also exceeded expectations. Adjusted EPS reached $0.94, exceeding the previous outlook of $0.85. The company remains confident in achieving its full-year organic growth target of 0% to 2%. Church & Dwight highlighted the acquisition of Touchland, which contributed positively to sales and market share in the hand sanitizer category. The company is undergoing a strategic review of its vitamin business, considering options such as potential joint ventures or divestitures due to mixed results in revitalization efforts. Despite challenges, the company is optimistic about its brand performance, new product launches, and continued share gains across key categories. The international segment reported a 5.3% sales growth, driven by higher volume, price, and mix. Looking ahead, Church & Dwight maintains a full-year adjusted EPS growth expectation of 0% to 2%, factoring in the Touchland acquisition and strategic exits of certain businesses.

Church & Dwight Financial Statement Overview

Summary
Church & Dwight exhibits a strong financial position with consistent revenue growth, solid profitability margins, and effective cash flow management. The balance sheet reflects moderate leverage, supporting financial stability. While there is room for improvement in net profit margins, the company's financial health is robust, positioning it well for future growth.
Income Statement
78
Positive
Church & Dwight shows a solid financial performance with a consistent increase in revenue, as evidenced by a TTM revenue growth rate of 1.24%. The gross profit margin remains strong at 44.44%, indicating efficient production and cost management. However, the net profit margin of 12.74% suggests room for improvement in controlling non-operating expenses. The EBIT and EBITDA margins are stable, reflecting effective operational management.
Balance Sheet
72
Positive
The company's balance sheet is relatively healthy with a debt-to-equity ratio of 0.52, indicating moderate leverage. The return on equity is robust at 23.52%, showcasing effective use of shareholder funds to generate profits. However, the equity ratio of 46.18% suggests a balanced but slightly lower reliance on equity financing compared to assets.
Cash Flow
75
Positive
Church & Dwight demonstrates strong cash flow management with a free cash flow growth rate of 9.88% in the TTM period. The operating cash flow to net income ratio is 1.46, indicating efficient conversion of net income into cash. The free cash flow to net income ratio of 0.89 suggests a healthy cash generation relative to net income, supporting future investments and debt servicing.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue6.14B6.11B5.87B5.38B5.19B4.90B
Gross Profit2.73B2.79B2.59B2.25B2.26B2.21B
EBITDA1.33B1.09B1.30B831.90M1.31B1.22B
Net Income782.50M585.30M755.60M413.90M827.50M785.90M
Balance Sheet
Total Assets9.14B8.88B8.57B8.35B8.00B7.41B
Cash, Cash Equivalents and Short-Term Investments305.30M964.10M344.50M270.30M240.60M183.10M
Total Debt2.20B2.41B2.61B2.85B2.73B2.36B
Total Liabilities4.92B4.52B4.71B4.86B4.76B4.39B
Stockholders Equity4.22B4.36B3.86B3.49B3.23B3.02B
Cash Flow
Free Cash Flow1.02B976.40M807.10M706.40M875.00M891.40M
Operating Cash Flow1.14B1.16B1.03B885.20M993.80M990.30M
Investing Cash Flow-770.50M-183.30M-234.30M-728.60M-682.00M-608.10M
Financing Cash Flow-819.00M-343.40M-725.60M-120.90M-252.10M-360.10M

Church & Dwight Technical Analysis

Technical Analysis Sentiment
Positive
Last Price87.69
Price Trends
50DMA
89.42
Negative
100DMA
92.42
Negative
200DMA
97.64
Negative
Market Momentum
MACD
-1.33
Positive
RSI
51.89
Neutral
STOCH
27.87
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CHD, the sentiment is Positive. The current price of 87.69 is above the 20-day moving average (MA) of 86.84, below the 50-day MA of 89.42, and below the 200-day MA of 97.64, indicating a neutral trend. The MACD of -1.33 indicates Positive momentum. The RSI at 51.89 is Neutral, neither overbought nor oversold. The STOCH value of 27.87 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CHD.

Church & Dwight Risk Analysis

Church & Dwight disclosed 34 risk factors in its most recent earnings report. Church & Dwight reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Church & Dwight Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
$351.37B21.9531.90%2.78%1.23%17.97%
$148.02B24.5728.36%3.17%-0.30%-14.60%
$21.36B27.6118.59%1.39%1.45%42.04%
$62.27B21.66450.35%2.67%-0.05%2.49%
$39.73B20.28136.87%4.18%-10.04%-23.41%
$20.33B14.63-3.31%3.23%1.93%-12.26%
$13.69B17.26249.61%4.37%0.16%191.17%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CHD
Church & Dwight
87.69
-14.07
-13.83%
CLX
Clorox
112.46
-44.14
-28.19%
CL
Colgate-Palmolive
77.05
-14.35
-15.70%
KMB
Kimberly Clark
119.71
-9.18
-7.12%
PG
Procter & Gamble
150.37
-10.46
-6.50%
UL
Unilever
60.19
0.87
1.47%

Church & Dwight Corporate Events

Church & Dwight Reports Q2 2025 Financial Results
Aug 2, 2025

Church & Dwight Co., Inc., a leading U.S. producer of sodium bicarbonate and a manufacturer of personal care, household, and specialty products, has reported its second quarter 2025 financial results. The company, known for its iconic ARM & HAMMER brand, continues to focus on innovation and sustainability in its operations.

Church & Dwight’s Earnings Call: Growth Amid Challenges
Aug 2, 2025

Church & Dwight’s Recent Earnings Call: A Mixed Bag of Growth and Challenges

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 01, 2025